Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/28/22
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 04/10/23
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients with Leukocyte Adhesion Deficiency Type II | NCT05462587 | AUG Therapeutics | user2@example.com | None | 2022-07-28 | 2024-11-30 | 2025-11-30 | - | - | 2025-07-14 |
| An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II | NCT05754450 | AUG Therapeutics | user2@example.com | None | 2023-04-10 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |